BahiaFarma, Biocon, Bionovis inks MoU in pharma sector

India and Brazil signed multiple Memoranda of Understanding (MoUs) during Brazilian President Lula da Silva's visit. Key agreements include a pact for developing a breast cancer medicine, cooperation in iron ore blending at Gangavaram Port, and R&D in strategic pharmaceutical ingredients. ApexBrasil and FICCI also agreed to boost trade and investment.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/PnhsZ48
via IFTTT

Read More

Quality Care India plans to invest Rs 600 crore to set up healthcare facility in Nagpur

Quality Care India Limited is set to invest Rs 600 crore in a new 350+ bed multi-speciality hospital in Nagpur. The facility, to be developed on Maha-Metro land near Kasturchand Park Metro Station, aims to strengthen healthcare infrastructure in Central India. This project, a public-private partnership, is expected to create over 1,500 jobs and enhance regional healthcare capacity.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9QZqgoM
via IFTTT

Read More

Novartis exits India arm, ChrysCapital-led group buys 70.68% stake for ₹1,446 crore

Swiss drugmaker Novartis AG is selling its 70.68% stake in its Indian unit for Rs 1,446 crore to a consortium led by ChrysCapital. This divestment aligns with Novartis' strategy to become a pure-play innovative medicines company, while it maintains a significant presence in India through its wholly owned subsidiary.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0hWX6Y8
via IFTTT

Read More

Drugmakers flag concerns over blue-strip antibiotic labels

The government mandated a blue line on antibiotic packaging to curb misuse. However, pharmaceutical companies argue this will disrupt operations and finances. They believe the measure lacks scientific backing and global alignment. Industry associations are urging the government to withdraw the notification. Existing regulations already address antimicrobial resistance concerns.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GuhQOfs
via IFTTT

Read More

ChrysCapital, two others launch open offer for Novartis India

A consortium including WaveRise Investments, ChrysCapital, and Two Infinity Partners is set to acquire a significant stake in Novartis India. This move is part of Novartis's strategy to divest its stake. The transaction is expected to conclude in the third quarter of 2026. Novartis will continue its operations in India through Novartis Healthcare.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/lQVLZwt
via IFTTT

Read More

Indian drugmaker Sai Life Sciences to boost headcount by about 20% amid global demand upswing

Sai Life Sciences will boost its workforce by over 700 employees next financial year. This expansion supports growing global demand for its services. The company is increasing capacity to meet this demand. New hires will focus on scientific, technical, and management roles. This move reflects a broader trend of global pharma companies expanding in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ExMusJk
via IFTTT

Read More

Thyroid, antibiotic drugs face fresh safety warnings after national review

New safety warnings are coming for two common medicines, doxycycline and carbimazole. Indian drug regulators have identified potential mental health side effects for doxycycline. Carbimazole will now carry stronger warnings about a rare but serious blood disorder. Manufacturers must update prescribing information. These changes aim to improve patient safety by highlighting important risks.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/H09vWqY
via IFTTT

Read More